1,377
Views
29
CrossRef citations to date
0
Altmetric
ARTICLES

Therapeutic Challenges in Cancer Pain Management: A Systematic Review of Methadone

Pages 197-205 | Received 19 Mar 2014, Accepted 19 May 2014, Published online: 07 Aug 2014

REFERENCES

  • Fredheim OMS, Moksnes K, Borchgrevink PC, Kaasa S, Dale O. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand. 2008;52:879–879.
  • Reddy S, Hui D, Osta BE, The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010;13:33–38.
  • Fainsinger R, Schoeller T, Bruera E. Methadone in the management of cancer pain: a review. Pain. 1993;52:137–147.
  • Twycross R. Opioid rotation: does it have a role? Palliat Med. 1998;12:60–63.
  • Nicholson AB. Methadone for cancer pain. Cochrane Database Syst Rev. 2007;4:CD003971.
  • Brown R, Kraus C, Fleming M, Reddy S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004;80:654–659.
  • Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41:1153–1193.
  • Prommer EE. Methadone for cancer pain. Palliat Care Res Treat. 2010;2010:1–10.
  • Bruera E, Palmer JL, Bosnjak S, Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol. 2004;22:185–192.
  • Mercadante S, Casuccio A, Agnello A, Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. J Clin Oncol. 1998;16:3656–3661.
  • Ventafridda V, Ripamonti C, Bianchi M, Sbanotto A, De Conno F. A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage. 1986;1:203–207.
  • Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25:297–312.
  • Grochow L, Sheidler V, Grossman S, Green L, Enterline J. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study. Pain. 1989;38:151–157.
  • Beaver WT, Wallenstein SL, Houde RW, Rogers A. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin Pharmacol Ther. 1967;8:415–426.
  • Ferrer-Brechner T, Ganz P. Combination therapy with ibuprofen and methadone for chronic cancer pain. Am J Med. 1984;77:78–83.
  • Matts SG. Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain. Postgrad Med J. 1964;40:103–105.
  • Jadad AR, Moore RA, Carroll D, Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
  • Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org. Updated March 2011. Accessed 23rd July 2014.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.2009.
  • Mercadante S, Porzio G, Ferrera P, Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12:1040–1046.
  • Lauretti GR, Rizzo CC, Mattos AL, Rodrigues SW. Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone. Br J Cancer. 2013;108:259–264.
  • Cubero DI, del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer. 2010;18:235–242.
  • Moksnes K, Dale O, Rosland JH, How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial. Eur J Cancer. 2011;47:2463–2470.
  • Sloan JA, Loprinzi CL, Kuross SA, Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–3673.
  • Aaronson NK, Ahmedzai S, Bergman B, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.